| 11/10/2026 10:24 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/09/2026 4:05 PM | Heron Therapeutics (818033) Filer | Form DEFA14A | |
| 11/09/2026 7:50 AM | Heron Therapeutics (818033) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 7:15 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/09/2026 7:20 AM | Heron Therapeutics (818033) Filer | Form DEFA14A | |
| 11/09/2026 6:40 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2026 11:57 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 11:50 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 11:53 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 11:54 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/27/2026 4:09 PM | Heron Therapeutics (818033) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for HRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/21/2026 11:00 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2026 11:01 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2026 11:03 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 4:00 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/10/2026 9:18 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 7:00 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/10/2026 7:00 AM | Heron Therapeutics (818033) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/03/2026 10:20 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 9:59 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 8:50 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 8:32 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:22 PM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:10 PM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 2:54 PM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 4:00 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 9:52 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 1:49 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/08/2026 9:27 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 4:15 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/13/2026 8:05 AM | Adage Capital Management, L.P. (1535978) Filed by Heron Therapeutics (818033) Subject | Form SCHEDULE 13G/A | |
| 05/11/2026 7:00 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/11/2026 7:00 AM | Heron Therapeutics (818033) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 12:01 PM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 11:49 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 11:35 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 10:56 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 10:30 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 1:09 PM | Heron Therapeutics (818033) Filer | Form DEF 14A | |
| 04/30/2026 1:09 PM | Heron Therapeutics (818033) Filer | Form DEFA14A | |
| 04/30/2026 1:10 PM | Heron Therapeutics (818033) Filer | Form ARS | |
What the hell is going on? (Ad) Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway.
The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December.
Watch Porter Stansberry's full broadcast to see which companies could be affected. Watch Porter Stansberry's full broadcast on the coming dollar reset now |
| 04/21/2026 10:15 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 8:41 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 8:13 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:13 PM | Heron Therapeutics (818033) Filer | Form PRE 14A | |
| 04/06/2026 6:06 PM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 7:30 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 8:30 AM | Heron Therapeutics (818033) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 02/26/2026 7:06 AM | Heron Therapeutics (818033) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 7:00 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 1:40 PM | Clearline Capital LP (1600136) Filed by Heron Therapeutics (818033) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 9:00 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Dissanaike Sharmila (1885069) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Cusack Thomas (2094824) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Heron Therapeutics (818033) Issuer Johnson Craig A (1370348) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Heron Therapeutics (818033) Issuer Kaseta Michael (1724346) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Christian Waage (1553179) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 8:15 AM | Heron Therapeutics (818033) Issuer Morgan Adam (1964335) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:30 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:30 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:30 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 2:00 PM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 1:39 PM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 1:49 PM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 12:08 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/26/2025 9:15 AM | Clearline Capital LP (1600136) Filed by Heron Therapeutics (818033) Subject | Form SCHEDULE 13G | |